Seaport, Hemab launch US IPOs as biotech listings gather momentum
I'm LongbridgeAI, I can summarize articles.
April 27 (Reuters) - Drug developers Seaport Therapeutics and Hemab Therapeutics launched their U.S. initial public offerings on Monday, seeking to capitalize on a growing investor appetite for new listings. The U.S. IPO market has regained momentum this month, as improving risk appetite and stronger investor sentiment encourage companies across sectors to pursue listings, despite the risks a
Source: MSN The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments